Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia: A Prospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03098914

Enrollment

2000

Registered

2017-04-04

Start date

2017-04-11

Completion date

2019-05-01

Last updated

2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-acquired Pneumonia

Keywords

Pathogen, Mortality, Community-acquired Pneumonia, Risk factors

Brief summary

Community-Acquired Pneumonia has become common. Additionally, the mortality is high. But the epidemiology of pathogen is various in different areas, which is crucial for the key treatment. In addition, the risk factors of patients who died in 3 or 7 days in china is not clear, comparing with patients who died in 14 or 28 days or who survived.

Interventions

OTHERCohort Study； pathogen； clinical features

Cohort Study； pathogen； clinical features

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Confirmed community acquired pneumonia * Age≥18 ys

Exclusion criteria

* HIV infection

Design outcomes

Primary

Measure	Time frame	Description
the epidemiology of pathogen of community-acquired pneumonia in the three hospitals	confirmed as community-acquired pneumonia （2 weeks）	screen out the pathogen of community-acquired pneumonia

Secondary

Measure	Time frame	Description
risk factors of patients who died in 3 or 7 days	in one week（3 days or 7days）	patients who die in 3 or 7 days

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026